Related Experiment Video
Updated: Jan 7, 2026

Transcranial Direct Current Stimulation tDCS for Memory Enhancement
Published on: September 18, 2021
Dementia Care Research and Psychosocial Factors
1Universidad de Costa Rica, San Jose, San Jose, Costa Rica; Hospital Mexico, Caja Costarricense de Seguro Social, San Jose, San Jose, Costa Rica.
Abstract:
Obtaining a diagnosis is key for patient autonomy and care planning. Accuracy in the diagnosis allows for tailored therapies and participation in clinical research. Likewise, a specific dementia diagnosis allows for better understanding of the symptoms and progression observed by patients and caregivers. Diagnosing a specific type of dementia in Latin America requires adapting guidelines to the available ancillary diagnostic tools. In the diagnostic formulation proposed by Dickerson, et al., there are three diagnostic tiers: 1. Cognitive Functional Status, 2. Cognitive-Behavioral Syndrome, and 3. Neurodegenerative Brain Disease. The cognitive functional status refers to how independent the person is, ranging from cognitively normal, to severe dementia. Our experience in Latin America is that families often compensate for patients' deficits and will most often minimize their level of impairment. This requires a careful understanding of the patient's baseline and current abilities. Defining the cognitive-behavioral syndrome refers to the clinical type of dementia. For example, amnestic multidomain dementia, behavioral variant frontotemporal dementia, posterior cortical atrophy, etc. We use the symptoms described by the patient and informants, in addition to the signs obtained through bedside and formal neuropsychological evaluations and the neurologic exam. Lastly, the neurodegenerative brain disease refers to the suspected underlying pathology (Alzheimer's disease, frontotemporal lobar degeneration, etc.). This information requires ancillary testing which will vary widely depending on the practice setting. Imaging techniques include both structural (CT, MRI) and functional (PET, SPECT). The underlying brain pathology may be specified in clinical practice with genetic testing and biomarkers. The latter includes fluid (blood-based and CSF), tissue (skin), and imaging (PET). One may use many combinations of the listed tools to reach the most precise diagnosis. In this presentation, we will provide a guide on best practices with an adaptation to the Latin American culture and combination of available resources.
More Related Videos
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
Related Concept Videos
Dementia
The progression of dementia is generally gradual....
Psychological and Sociocultural Causes of Schizophrenia
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Cognitive Development During Adulthood
Documentation in Long-Term and Home Healthcare Setting
Long-Term Care Facilities